Episode Mentions
Vital Dawn · Apr 29, 2026
Vital Dawn Podcast for Wednesday April 29
“European pharmaceutical company with disappointing Q1 earnings results”
Q1 2024 Earnings Season Peak VolumeSemiconductor Industry AI Demand TrendsConsumer Spending Resilience
View Analysis
The a16z Show · Feb 16, 2026
Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company
“Spun off as standalone public company, originally part of Novartis conglomerate”
Corporate transformation and spin-offsCell and gene therapy platformsRNA therapeutics and siRNA technology
View Analysis
The Peter Attia Drive · Nov 17, 2025
#373 – Thyroid function and hypothyroidism: why current diagnosis and treatment fall short for many, and how new approaches are transforming care | Antonio Bianco, M.D., Ph.D.
“Generic levothyroxine manufacturer mentioned in discussion of brand-name versus generic thyroid hormone formulations”
Thyroid hormone physiology and deiodinase enzyme function (D1, D2, D3)TSH limitations as a diagnostic and treatment target markerFree T3 and reverse T3 measurement accuracy and clinical utility
View Analysis
Lex Fridman Podcast · Sep 19, 2025
#481 – Norman Ohler: Hitler, Nazis, Drugs, WW2, Blitzkrieg, LSD, MKUltra & CIA
“Swiss pharmaceutical company where Albert Hofmann synthesized LSD in 1943; CEO Stoll later sold LSD supply to CIA for MK-Ultra program”
Nazi Germany Drug Use and Military StrategyMethamphetamine (Pervitin) in Wehrmacht OperationsHitler's Opioid Addiction and Decision-Making Decline
View Analysis